ConforMIS, Inc. – Trademark Portfolio
Entity Type: 03
ConforMIS, Inc. holds 42 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 33 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 11 trademarks are registered. Notable registered marks include C, IFIT, IJIG, IPOLY, and IVIEW. The owner is based in Billerica, MA.
600 Technology Park Drive
Billerica, MA 01821
Showing of trademarks Trademarks
Trademark Classifications
ConforMIS, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does ConforMIS, Inc. have?
ConforMIS, Inc. has 42 U.S. trademarks filed with the USPTO. Of these, 11 registered, 26 abandoned, 5 cancelled.
What trademark classes does ConforMIS, Inc. file in?
ConforMIS, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 44 (Medical Services). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are ConforMIS, Inc.'s most well-known trademarks?
ConforMIS, Inc.'s registered trademark portfolio includes well-known marks such as C, IFIT, IJIG, IPOLY, and IVIEW. These are among 11 currently registered trademarks in the portfolio.
What is ConforMIS, Inc.'s trademark registration success rate?
ConforMIS, Inc. has a 26% trademark registration rate, with 11 out of 42 resolved applications resulting in successful registration. Currently, 0 applications are pending review.